Jan 26 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* REPORT ON OPERATIONS 2022
* Q4 NET SALES SEK 131.5 MILLION VERSUS SEK 85.9 MILLION
YEAR AGO
* Q4 ADJUSTED EBITDA SEK 19.8 MILLION VERSUS SEK 9.6 MILLION
YEAR
AGO
* Q4 NET PROFIT SEK 0.7 MILLION VERSUS NET SEK 12.2 MILLION
YEAR
AGO
* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR
2022
FINANCIAL YEAR AND THAT RETAINED EARNINGS BE CARRIED FORWARD
Source text for Eikon: ID:nMFNGf7H0
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))